Bookmark

Add to MyYahoo RSS

Guidant News

News on Guidant (Ticker: BSX) continually updated from thousands of sources around the net.

Tuesday Aug 12 | Business Journal

Manhunt on for bar co-founder wanted in executive's shooting death

Police are searching for the co-founder of a Minneapolis bar who is a suspect in the fatal shooting of his former business partner, a Boston Scientific executive.

Comment?

Related Topix: Violent Crime, Startups, Arden Hills, MN

Thu Aug 07, 2014

Sys-Con Media

Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces...

Such investors are advised to contact Boston Scientific disclosed in a regulatory filing that it received a "subpoena from the U.S. Attorney for the District of , including information relating to its sale of CrossBoss and Stingray products, educational and training activities that relate to those sales and our acquisition of BridgePoint Medical."

Comment?

Related Topix: Medicine, Boston Scientific, Medical Equipment, Healthcare Industry, Advanced Bionics, Startups, SSI Technologies, Balloon

Wed Jul 30, 2014

Business Journal

Boston Scientific prevails in first of thousands of mesh lawsuits

Shares in Boston Scientific shot up this afternoon following the news that the medical device company has been found not liable in the first of thousands of lawsuits over its transvaginal mesh.

Comment?

Related Topix: Advanced Bionics, Startups, Boston Scientific, Medicine, SSI Technologies, Balloon, Medical Equipment, Healthcare Industry

Tue Jul 29, 2014

AmericanBankingNews.com

Boston Scientific Now Covered by Sterne Agee

The firm set a "neutral" rating and a $13.50 price target on the stock. Sterne Agee's price objective suggests a potential upside of 4.09% from the stock's previous close.

Comment?

Related Topix: Medicine, Boston Scientific, Medical Equipment, Healthcare Industry, Advanced Bionics, Startups, SSI Technologies, Balloon

Mon Jul 21, 2014

Freshnews

Boston Scientific Receives FDA Approval for REBEL(TM) Platinum Chromium Coronary Stent System

Boston Scientific Corporation has received FDA approval for the REBEL Platinum Chromium Coronary Stent System, the company's latest generation bare-metal stent for the treatment of coronary artery disease .

Comment?

Related Topix: Medicine, Boston Scientific, Medical Equipment, Healthcare Industry, Advanced Bionics, Startups, SSI Technologies, Balloon

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••